Revance Therapeutics to Release Second Quarter 2018 Financial Results on Thursday, August 2, 2018
-Conference Call Scheduled for
Individuals interested in listening to the conference call may do so by dialing (855) 453-3827 for domestic callers, or (484) 756-4301 for international callers and reference conference ID: 3480629; or from the webcast link in the investor relations section of the company's website at: www.revance.com.
A replay of the call will be available beginning August 2,
2018 at 4:30pm PT/7:30pm ET to August 3, 2018 at 4:30pm PT/
About Revance Therapeutics, Inc.
Revance Therapeutics, Inc.:
Jeanie Herbert, 714-325-3584
Burns McClellan, Inc.:
Ami Bavishi, 212-213-0006
Mariann Caprino, 917-242-1087
Nadine Tosk, 504-453-8344